Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to observe the tolerability and effectiveness of Kaletra in Human
Immunodeficiency Virus/Hepatitis-B Virus and Human Immunodeficiency Virus/Hepatitis-C Virus
co-infected patients.